| Literature DB >> 26520391 |
Ferenc Zádor1, Maria Wollemann2.
Abstract
A growing amount of data demonstrates the interactions between cannabinoid, opioid and the transient receptor potential (TRP) vanilloid type 1 (TRPV1) receptors. These interactions can be bidirectional, inhibitory or excitatory, acute or chronic in their nature, and arise both at the molecular level (structurally and functionally) and in physiological processes, such as pain modulation or perception. The interactions of these three pain-related receptors may also reserve important and new therapeutic applications for the treatment of chronic pain or inflammation. In this review, we summarize the main findings on the interactions between the cannabinoid, opioid and the TRPV1 receptor regarding to pain modulation.Entities:
Keywords: Cannabinoid receptor; Opioid receptor; Pain; Receptor interaction; TRPV1 receptor
Mesh:
Substances:
Year: 2015 PMID: 26520391 DOI: 10.1016/j.phrs.2015.10.015
Source DB: PubMed Journal: Pharmacol Res ISSN: 1043-6618 Impact factor: 7.658